Myriad Genetics Stock Price (NASDAQ:MYGN)

Add to My Stocks
$23.86 $0.3 (1.24%) MYGN stock closing price Jul 25, 2017 (Closing)
Prev Close* : $24.16
Market Cap:
$1.65B
Day Low: $23.8
52 Week Low: $15.15
Open: $24.23
Volume: 757283
Day High: $24.3
52 Week High: $32.54
Dividend:
N/A

Latest Stock Market News

Latest Articles

Myriad Genetics News - From Partners

MYGN Stockcharts

View MYGN PE ratio, PS ratio stocks charts and compare with peers.
MYGN Chart
Note: Compare Myriad Genetics stock price history with the index and industry peers.

Myriad Genetics Valuation

PE ratio
(price earnings ratio)
53.02
PS ratio (
price to sales ratio
)
2.15
PB ratio (
price to book ratio
)
2.18

Myriad Genetics Returns

ROE
(return on equity)
4%

Myriad Genetics Financial Ratios

Asset Turnover
0.62
Receivables Turnover
7.25
Debt to Equity
0.22

MYGN Industry Peers

Company Price Change (%)
Amicus Therapeutics (FOLD)13.740.01 (0.07%)
Bavarian Nordic (BVNRY)20.370.44 (2.21%)
Foundation Medicine (FMI)37.30.2 (0.53%)
Oncocyte (OCX)4.350.15 (3.57%)
Genomic Health (GHDX)32.940.1 (0.3%)
Interleukin Genetics (ILIU)0.010 (0%)
Fulgent Genetic (FLGT)6.530.09 (1.36%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Compugen (CGEN)4.050.65 (19.12%)
Idera Pharma (IDRA)2.060.14 (7.29%)
Merrimack Pharma (MACK)1.360.05 (3.82%)
PDL BioPharma (PDLI)2.460.08 (3.36%)
Horizon Pharma (HZNP)13.480.32 (2.43%)
Keryx Biopharma (KERX)7.450.16 (2.19%)
Acorda Therapeutics (ACOR)22.850.45 (2.01%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 26, 2017
CompanyPriceChange (%)
Novavax (NVAX)1.10.41 (27.15%)
Dynavax Technologies (DVAX)9.90.75 (7.04%)
Vital Therapies (VTL)2.650.15 (5.36%)
EXACT Sciences (EXAS)37.332.11 (5.35%)
China Biologic Products (CBPO)98.325.05 (4.89%)
Epizyme (EPZM)12.650.65 (4.89%)
Trevena (TRVN)2.820.14 (4.73%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 26, 2017

Myriad Genetics, Inc. Stock News - Partner Headlines

Myriad Genetics Financial Statements

income statement20162015201420132012
Net Sales Or Revenues753.8M723.1M778.21M613.16M496M
Net Income125.3M80.2M176.22M147.13M112.15M
Total Operating Expense429.7M441.5M394.56M305.53M251.02M
view Myriad Genetics, Inc. income statement
balance sheet20162015201420132012
Total Assets880.5M766.2M823.81M803.82M690.63M
Total Liabilities132.4M104.1M104.81M75.22M54.97M
Shareholders Equity748.1M662.1M718.99M728.59M635.66M
view Myriad Genetics, Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-65.4M-40.7M-59.97M-41.02M-28.76M
Net Cash From (Used By) Operating Activities166.3M140.5M190.21M173.86M141.84M
Increase (Decrease) In Prop Plant And Equipment-5M-23.9M-14.27M-11.37M-9.4M
view Myriad Genetics, Inc. cashflow statement

Myriad Genetics Stock Message Board

An investor needs to spend 23.86 to buy MYGN stock, as the closing Myriad Genetics stock price is 23.86. Myriad Genetics market capitalization is 1.65B and it represents the total market value of MYGN stock. Myriad Genetics valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Myriad Genetics is worth a lot, it will most likely be reflected in an inflated Myriad Genetics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 757283 MYGN shares were traded yesterday, and Myriad Genetics stock chart shows that the MYGN stock quote hit a day high of 24.3 and day low of 23.8. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Myriad Genetics stock price history, gives the entire historical data for MYGN stock.